These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10784623)

  • 21. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
    Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia: a metaphase-FISH study.
    el-Rifai W; Ruutu T; Vettenranta K; Temtamy S; Knuutila S
    Br J Haematol; 1996 Feb; 92(2):365-9. PubMed ID: 8603001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relapse after allogeneic bone marrow transplantation for Philadelphia chromosome positive chronic myeloid leukemia: cytogenetic analysis of 24 patients.
    Zaccaria A; Rosti G; Sessarego M; Frassoni F; Marmont A; Galimberti M; Baronciani D; Filippetti A; Di Bartolomeo P; Di Girolamo G
    Bone Marrow Transplant; 1988 Sep; 3(5):413-23. PubMed ID: 3056550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reconstitution with Philadelphia chromosome-negative recipient haematopoiesis early after allogeneic BMT for CML.
    Sill H; Rule SA; Joske DJ; Chase A; Lin F; Goldman JM; Cross NC
    Bone Marrow Transplant; 1996 Mar; 17(3):453-5. PubMed ID: 8704706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Monitoring of bcr/abl fusion gene by interphase-dual-color and dual-fusion fluorescence in situ hybridization in CML after allo-HSCT].
    Qian SX; Li JY; Zhang R; Hong M; Qiu HR; Li L; Xu W; Sheng RL; Wu HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):577-81. PubMed ID: 16800946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic role of conventional cytogenetics and fluorescence in situ hybridization (FISH) in chronic myeloid leukemia patients.
    Jha CB; Kucheria K; Choudhary VP
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):171-5. PubMed ID: 18603893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation.
    Offit K; Burns JP; Cunningham I; Jhanwar SC; Black P; Kernan NA; O'Reilly RJ; Chaganti RS
    Blood; 1990 Mar; 75(6):1346-55. PubMed ID: 2310831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mixed chimerism of the resident macrophage population after allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Wickenhauser C; Thiele J; Pérez F; Varus E; Stoffel MS; Kvasnicka HM; Beelen DW; Schaefer UW
    Transplantation; 2002 Jan; 73(1):104-11. PubMed ID: 11792988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone marrow transplantation for Philadelphia-chromosome positive chronic myelogenous leukemia.
    Elmaagacli AH; Becks HW; Beelen DW; Stockova J; Bützler R; Opalka B; Schaefer UW
    Bone Marrow Transplant; 1995 Dec; 16(6):823-9. PubMed ID: 8750276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relapse after allogeneic BMT for chronic myeloid leukemia (CML) may be sustained by a small number of leukemic 'stem cells': a hypothesis.
    Frassoni F; Podestà M; Piaggio G; Pitto A; Figari O; Soracco M; Lint M; Fugazza G; Sessarego M; Bacigalupo A
    Bone Marrow Transplant; 1999 Sep; 24(6):689-91. PubMed ID: 10490738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serial cytogenetic studies in allografted patients with chronic myeloid leukemia.
    Bilhou-Nabera C; Bernard P; Marit G; Viard F; Gharbi MJ; Wen Z; Lacombe F; Broustet A; Reiffers J
    Bone Marrow Transplant; 1992 Apr; 9(4):263-8. PubMed ID: 1600414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.
    Paschka P; Müller MC; Merx K; Kreil S; Schoch C; Lahaye T; Weisser A; Petzold A; König H; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
    Leukemia; 2003 Sep; 17(9):1687-94. PubMed ID: 12970765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-random involvement of chromosome 13 in patients with persistent or relapsed disease after bone-marrow transplantation for chronic myeloid leukemia.
    Chase A; Pickard J; Szydlo R; Coulthard S; Goldman JM; Cross NC
    Genes Chromosomes Cancer; 2000 Mar; 27(3):278-84. PubMed ID: 10679917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Study of FISH, PCR and Cytogenetics on 25 Patients Submitted to Bone Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML); Which Tests can we Use in Routine Analysis Post BMT?
    Palka G; Lawler M; Morizio E; Gardiner N; Stuppia L; De Arce MA; Di Bartolomeo PD; Capodiferro F; Sabatino G; Gatta V; Calabrese G; Cann SR
    Hematology; 1998; 3(3):193-203. PubMed ID: 27416528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytogenetics of chronic myelogenous leukaemia.
    O'Brien S; Thall PF; Siciliano MJ
    Baillieres Clin Haematol; 1997 Jun; 10(2):259-76. PubMed ID: 9376663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of bcr-abl fusion transcripts following bone marrow transplantation for Philadelphia chromosome-positive leukemia.
    Kohler S; Galili N; Sklar JL; Donlon TA; Blume KG; Cleary ML
    Leukemia; 1990 Aug; 4(8):541-7. PubMed ID: 2201832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mixed chimerism of bone marrow vessels (endothelial cells, myofibroblasts) following allogeneic transplantation for chronic myelogenous leukemia.
    Kvasnicka HM; Wickenhauser C; Thiele J; Varus E; Hamm K; Beelen DW; Schaefer UW
    Leuk Lymphoma; 2003 Feb; 44(2):321-8. PubMed ID: 12688352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Durable molecular remission in a patient with chronic myelogenous leukemia and host-derived hematopoiesis after allogeneic bone marrow transplantation.
    Wakui M; Okamoto S; Ishida A; Tanosaki R; Mori T; Kawai Y; Ohshima S; Ikeda Y
    Bone Marrow Transplant; 1996 Oct; 18(4):801-4. PubMed ID: 8899199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytogenetic patterns following bone marrow transplantation for chronic granulocytic leukemia.
    da Silva MA; Heerema NA; Lowe LR; Tricot G; Jansen J
    Cancer Genet Cytogenet; 1988 Nov; 36(1):35-44. PubMed ID: 3060250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.